Drug Shortage Report for M-RANITIDINE
| Report ID | 108892 |
| Drug Identification Number | 02473534 |
| Brand name | M-RANITIDINE |
| Common or Proper name | Ranitidine |
| Company Name | MANTRA PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-09-13 |
| Estimated end date | Unknown |
| Actual end date | 2020-09-14 |
| Shortage status | Resolved |
| Updated date | 2020-09-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-09-17 | French | Compare |
| v3 | 2020-09-17 | English | Compare |
| v2 | 2020-03-18 | French | Compare |
| v1 | 2020-03-18 | English | Compare |
Showing 1 to 4 of 4